Cargando…
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells
Ribonucleases represent a new class of antitumor RNA-damaging drugs. However, many wild-type members of the vertebrate secreted ribonuclease family are not cytotoxic because they are not able to evade the cytosolic ribonuclease inhibitor. We previously engineered the human pancreatic ribonuclease to...
Autores principales: | Vert, Anna, Castro, Jessica, Ribó, Marc, Benito, Antoni, Vilanova, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951290/ https://www.ncbi.nlm.nih.gov/pubmed/26918450 http://dx.doi.org/10.18632/oncotarget.7579 |
Ejemplares similares
-
Construction of Highly Stable Cytotoxic Nuclear-Directed Ribonucleases
por: Roura Padrosa, David, et al.
Publicado: (2018) -
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
por: Castro, Jessica, et al.
Publicado: (2021) -
A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells
por: Castro, Jessica, et al.
Publicado: (2021) -
A human ribonuclease induces apoptosis associated with p21(WAF1/CIP1 )induction and JNK inactivation
por: Castro, Jessica, et al.
Publicado: (2011) -
Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance
por: Vert, Anna, et al.
Publicado: (2018)